Kenvue Inc. Plans Quarterly Dividend of $0.21 (NYSE:KVUE)

Kenvue Inc. (NYSE:KVUE) declared a quarterly dividend on Wednesday, April 29th. Stockholders of record on Wednesday, May 13th will be given a dividend of 0.2075 per share on Wednesday, May 27th. This represents a c) dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date is Wednesday, May 13th.

Kenvue has a payout ratio of 68.0% meaning its dividend is sufficiently covered by earnings. Analysts expect Kenvue to earn $1.16 per share next year, which means the company should continue to be able to cover its $0.83 annual dividend with an expected future payout ratio of 71.6%.

Kenvue Price Performance

NYSE KVUE opened at $17.21 on Thursday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.96. The firm’s 50 day moving average price is $17.75 and its 200-day moving average price is $17.17. Kenvue has a 52-week low of $14.02 and a 52-week high of $25.17. The company has a market cap of $33.03 billion, a PE ratio of 22.34, a P/E/G ratio of 3.98 and a beta of 0.61.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The firm had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $3.68 billion. During the same period last year, the firm earned $0.26 earnings per share. The company’s quarterly revenue was up 3.2% on a year-over-year basis. Sell-side analysts forecast that Kenvue will post 1.1 EPS for the current fiscal year.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.